• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

震颤麻痹的流行病学研究追踪指标。五、瑞典各郡该疾病的患病率。

Tracers for paralysis agitans in epidemiological research. V. Prevalence of the disease in Swedish counties.

作者信息

de Pedro J

出版信息

Neuroepidemiology. 1986;5(4):207-19. doi: 10.1159/000110830.

DOI:10.1159/000110830
PMID:3561654
Abstract

The prevalence of parkinsonism varies severalfold between different countries in the world. This could be due to an accumulation of risk factors in certain areas. In the present paper we have analyzed the regional distribution of parkinsonism in Sweden in order to see if such areas could be found within one country. The study was based on sales of levodopa in the different counties of Sweden, and the results were standardized for age and quality of health services as indicated by the local infant mortality rates. The mean prevalence of the different Swedish counties was estimated to be in the middle range of known prevalences. There was a 60% variation within Sweden between the different counties, but the regional distribution did not show a systematic pattern. Further analysis of the causes for this variation showed that differences in case ascertainment and in drug policy could well account for the observed regional differences in parkinsonism prevalence.

摘要

帕金森症的患病率在世界不同国家之间相差数倍。这可能是由于某些地区风险因素的累积。在本文中,我们分析了瑞典帕金森症的区域分布情况,以确定在一个国家内是否能找到此类地区。该研究基于瑞典不同郡县左旋多巴的销售情况,并根据当地婴儿死亡率所反映的年龄和卫生服务质量对结果进行了标准化处理。瑞典不同郡县的平均患病率估计处于已知患病率的中等范围。瑞典不同郡县之间存在60%的差异,但区域分布并未呈现出系统模式。对这种差异原因的进一步分析表明,病例确诊和药物政策的差异很可能解释了观察到的帕金森症患病率的区域差异。

相似文献

1
Tracers for paralysis agitans in epidemiological research. V. Prevalence of the disease in Swedish counties.震颤麻痹的流行病学研究追踪指标。五、瑞典各郡该疾病的患病率。
Neuroepidemiology. 1986;5(4):207-19. doi: 10.1159/000110830.
2
Studies on the prevalence of paralysis agitans by tracer methodology.用示踪方法对帕金森病患病率的研究。
Acta Neurol Scand Suppl. 1987;112:1-106.
3
Tracers for paralysis agitans in epidemiological research. IV. Trends in national drug policy and measurement of the prevalence of the disease in Sweden.流行病学研究中帕金森病的追踪指标。IV. 瑞典国家药物政策趋势及疾病患病率测量
Neuroepidemiology. 1985;4(3):176-85. doi: 10.1159/000110228.
4
Tracers for paralysis agitans in epidemiological research. III. Refinement of the model for estimation of the prevalence of the disease.震颤麻痹流行病学研究中的追踪指标。III. 疾病患病率估计模型的完善
Neuroepidemiology. 1985;4(3):161-75. doi: 10.1159/000110227.
5
High levodopa use in periodically time-clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology? Europarkinson Preparatory Activity Research Group.冰岛出生队列中左旋多巴在特定时间聚集期的高剂量使用。帕金森病病因的一种残留现象?欧洲帕金森病前期活动研究小组
Acta Neurol Scand. 1995 Feb;91(2):79-88. doi: 10.1111/j.1600-0404.1995.tb00412.x.
6
Levodopa use in Denmark: high levels in Greenland and the Faroe Islands. Europarkinson Preparatory Activity Research Group.
Acta Neurol Scand. 1995 Feb;91(2):89-97. doi: 10.1111/j.1600-0404.1995.tb00413.x.
7
Utilization of antiparkinsonian drugs in Sweden, 1974-1987.1974 - 1987年瑞典抗帕金森病药物的使用情况
Adv Neurol. 1990;53:387-9.
8
[Long-term treatment of middle-aged and old patients with paralysis agitans and parkinsonism with levodopa].左旋多巴对中老年震颤麻痹和帕金森病患者的长期治疗
Vrach Delo. 1975 Aug(8):126-30.
9
Epidemiological assessment of levodopa use by populations.人群使用左旋多巴的流行病学评估。
Acta Neurol Scand. 1991 May;83(5):328-35. doi: 10.1111/j.1600-0404.1991.tb04711.x.
10
Prevalence of older people with intellectual disability in Sweden: a spatial epidemiological analysis.瑞典智障老年人的患病率:一项空间流行病学分析。
J Intellect Disabil Res. 2015 Dec;59(12):1155-67. doi: 10.1111/jir.12219. Epub 2015 Aug 26.